Novasomes as Nano-Vesicular Carriers to Enhance Topical Delivery of Fluconazole: A New Approach to Treat Fungal Infections
暂无分享,去创建一个
A. Rasul | Yosif Almoshari | A. Khames | Ghulam Abbas | Shahid Shah | Meshal Alshamrani | N. Islam | M. Ahmed | Nader Namazi | Demiana M. Naguib | Mohammed A. S. Abourehab | Zunera Chauhdary | M. Saadullah | A. Salawi | I. Fatima | Sajid Mehmood Khan
[1] Marzina Ajrin,et al. Proniosome: A Promising Approach for Vesicular Drug Delivery. , 2021, Turkish journal of pharmaceutical sciences.
[2] Khalid J. Alzahrani,et al. Formulation Development, Characterization and Antifungal Evaluation of Chitosan NPs for Topical Delivery of Voriconazole In Vitro and Ex Vivo , 2021, Polymers.
[3] Apichart Atipairin,et al. Formula Development of Red Palm (Elaeis guineensis) Fruit Extract Loaded with Solid Lipid Nanoparticles Containing Creams and Its Anti-Aging Efficacy in Healthy Volunteers , 2021, Cosmetics.
[4] S. Nair,et al. NOVASOME: A PIONEERING ADVANCEMENTIN VESICULAR DRUG DELIVERY , 2021, International Journal of Applied Pharmaceutics.
[5] Ahmed Abdelbary,et al. Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation , 2021, International journal of nanomedicine.
[6] S. Mirzaeei,et al. A Review on Ocular Novel Drug Delivery Systems of Antifungal Drugs: Functional Evaluation and Comparison of Conventional and Novel Dosage Forms , 2020, Advanced pharmaceutical bulletin.
[7] Chih-Jung Chang,et al. Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains , 2020, Molecules.
[8] Andrey Kuskov,et al. Modulation of Entrapment Efficiency and In Vitro Release Properties of BSA-Loaded Chitosan Microparticles Cross-Linked with Citric Acid as a Potential Protein–Drug Delivery System , 2020, Materials.
[9] G. M. Soliman,et al. Spironolactone-Loaded LeciPlexes as Potential Topical Delivery Systems for Female Acne: In Vitro Appraisal and Ex Vivo Skin Permeability Studies , 2019, Pharmaceutics.
[10] P. Szymczyk,et al. Stabilisation and Growth of Metastable Form II of Fluconazole in Amorphous Solid Dispersions , 2019, Pharmaceutics.
[11] D. Murzin,et al. Zeta Potential of Beta Zeolites: Influence of Structure, Acidity, pH, Temperature and Concentration , 2018, Molecules.
[12] E. Bendas,et al. Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study , 2017, Drug delivery.
[13] Mirza Salman Baig,et al. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. , 2016, International journal of biological macromolecules.
[14] P. Dunlop,et al. Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants , 2016, Biotechnology Letters.
[15] M. Balouiri,et al. Methods for in vitro evaluating antimicrobial activity: A review☆ , 2015, Journal of pharmaceutical analysis.
[16] Bin Zhang,et al. Dispersion Process and Effect of Oleic Acid on Properties of Cellulose Sulfate- Oleic Acid Composite Film , 2015, Materials.
[17] Jun-Ho Kim,et al. Evaluation of silica nanoparticle toxicity after topical exposure for 90 days , 2014, International journal of nanomedicine.
[18] L. Kumar,et al. Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review , 2014, Artificial cells, nanomedicine, and biotechnology.
[19] S. Jose,et al. Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation , 2011, Journal of advanced pharmaceutical technology & research.
[20] A. Fadda,et al. Vesicular carriers for dermal drug delivery , 2009, Expert opinion on drug delivery.
[21] M. Tunney,et al. Rapid Colorimetric Assay for Antimicrobial Susceptibility Testing of Pseudomonas aeruginosa , 2004, Antimicrobial Agents and Chemotherapy.
[22] Christopher P. Austin,et al. Cell Viability Assays -- Assay Guidance Manual , 2004 .